Delivery Order SPE2DB22D2214-SPE2DB24FS5VJ
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,921.84, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 31, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,179.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,367.48 and is a Firm Fixed Price delivery order with an ultimate completion date of April 2, 2025. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a medical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,881.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is April 15, 2025. The contract does not have a set-aside designation, indicating open...
This federal contract award, valued at $18,353.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with a performance period ending on August 11, 2023. The contract has a Firm Fixed Price pricing type and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit...
This federal contract award, valued at $30,212.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed price agreement. The contract is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $348,555.25 Firm Fixed Price Delivery Order contract is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of July 19, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award is a delivery order valued at $37,825.20 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, with an ultimate completion date of May 28, 2025. The contract is a firm fixed-price arrangement and is not set aside for any particular business type. AmerisourceBergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $325,426.28. It is for the provision of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, with a completion date of July 9, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,910.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of July 9, 2024. The contract does not have a set-aside designation, indicating open competition....